US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LadRx Corporation

0.0014

-0.1021-98.65%

Volume:106.00

Turnover:0.20

Market Cap:693.13

PE:0.00

High:0.0014

Open:0.0014

Low:0.0014

Close:0.1035

52wk High:2.40

52wk Low:0.0001

Shares:495.09K

Float Shares:485.73K

Volume Ratio:5.96

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.0409

EPS(LYR):-3.2109

ROE:-653.73%

ROA:-176.86%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

LadRx Corporation

Exchange:

EXPERT

Establishment Date:

1985

Employees:

2

Office Location:

11726 San Vicente Boulevard,Suite 650,Los Angeles,California,United States

Website:

http://cytrx.com

Zip Code:

90049

Phone:

Fax:

310 826 6139

Introduction:

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer. Further, the company's Linker Activated Drug Release technology platform consists of an organic backbone, as well as develops albumin companion diagnostic to identify patients with cancer. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LADX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LADX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LADX\",,,,,undefined,":{"symbol":"LADX","market":"US","secType":"STK","nameCN":"LadRx Corporation","latestPrice":0.0014,"timestamp":1771621200000,"preClose":0.1035,"halted":0,"volume":106,"delay":15,"changeRate":-0.9864734299516909,"floatShares":485728,"shares":495092,"eps":-5.040903,"marketStatus":"Market Closed","change":-0.1021,"latestTime":"02-20 16:00:00 EST Delay","open":0.0014,"high":0.0014,"low":0.0014,"amount":0.1972,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-5.040903,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.1035,"volumeRatio":5.95505952531434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LADX\",,,,,undefined,":{"symbol":"LADX","floatShares":485728,"roa":"-176.86%","roe":"-653.73%","lyrEps":-3.210888,"volumeRatio":5.95505952531434,"shares":495092,"dividePrice":0,"high":0.0014,"amplitude":0,"preClose":0.1035,"low":0.0014,"week52Low":0.0001,"pbRate":"-0.00","week52High":2.4,"institutionHeld":0,"latestPrice":0.0014,"eps":-5.040903,"divideRate":0,"volume":106,"delay":15,"ttmEps":-5.040903,"open":0.0014,"prevYearClose":0.011,"prevWeekClose":0.1035,"prevMonthClose":0.1035,"prevQuarterClose":0.011,"fiveDayClose":0.1035,"twentyDayClose":0.1035,"sixtyDayClose":0.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LADX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-14","symbol":"LADX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-14","symbol":"LADX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"LADX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-03-27","symbol":"LADX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711512000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"LADX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LADX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LADX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":265412,"yearFounded":1985,"employeeNum":2,"address":"11726 San Vicente Boulevard,Suite 650,Los Angeles,California,United States","zipCode":"90049","officePhone":"310 826 5648","officeFax":"310 826 6139"},"stockCompanyDetail":{"websiteUrl":"http://cytrx.com","description":"LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer. Further, the company's Linker Activated Drug Release technology platform consists of an organic backbone, as well as develops albumin companion diagnostic to identify patients with cancer. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.","exchange":"EXPERT","name":"LadRx Corporation","nameEN":"LadRx Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LADX\",market:\"US\",,,undefined,":null}}